Approval · Notice of Compliance 18032 · 2016
STARTECT: Notice of Compliance 18032
Issued April 27, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18032
- Date
- April 27, 2016
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STARTECT | 02454327 | Dormant |
Medicinal ingredients
- ABAMECTIN 1 MG per ML
- DERQUANTEL 10 MG per ML